Preliminary results of two large immune therapy studies show promise in advanced cervical cancer

Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.

Leave a Reply

Your email address will not be published. Required fields are marked *